Clinical Trials
9
Active:6
Completed:1
Trial Phases
3 Phases
Phase 1:6
Phase 3:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (66.7%)Not Applicable
2 (22.2%)Phase 3
1 (11.1%)Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865379
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865457
Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis
Phase 3
Completed
- Conditions
- OsteoarthritisOsteoarthritis, Knee
- Interventions
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 380
- Registration Number
- NCT02688400
- Locations
- 🇦🇹
State Hospital Stockerau Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria
🇧🇪Institut Médical Spécialisé - Centre DISCCA, Hornu, Belgium
🇧🇪Reumatologie Medizorg Merksem, Merksem, Belgium
News
No news found